Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT06718205 · RECRUITING
Trial details
- NCT number
- NCT06718205
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-08
- Primary completion
- 2025-09-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.